hsa-miR-146a

ncRNA information

ncRNA name

hsa-miR-146a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

CHOP

Cancer information

Cancer name

Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Abnormally expressed miR-146a in lung cancer cells does not affect growth, but rather alters chemotherapy sensitivity.

Tissue resource

lung adenocarcinoma tumor tissues

human lung cancer cell lines A549

human lung cancer cell lines H446

human lung cancer cisplatin-resistant cell lines A549/CDDP

human lung cancer cisplatin-resistant cell lines H446/CDDP

Experiment

qRT-PCR,Dual-luciferase reporter assay


Institute

the Southwest Hospital of Third Military Medical University

Country

China

Continent

Asia